<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
----------------
Date of Report (Date of earliest event reported): NOVEMBER 28, 2000
IBIS TECHNOLOGY CORPORATION
(Exact name of registrant as specified in its charter)
MASSACHUSETTS 0-23150 04-2987600
---------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
32 CHERRY HILL DRIVE, DANVERS, MASSACHUSETTS 01923
------------------------------------------------ -------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (978) 777-4247
--------------
<PAGE>
ITEM 5. OTHER EVENTS.
On November 28, 2000 the Registrant publicly disseminated a press
release reiterating the estimates it made during its third quarter conference
call held on October 26, 2000. The Registrant's President and Chief Executive
Officer, Martin J. Reid, stated that the Registrant continues to stand by its
estimates discussed during its last conference call and that with additional
implanters coming on-line, it believes that fourth quarter wafer sales will
increase approximately 130% over the fourth quarter of 1999, or 50%
sequential growth over the third quarter of 2000. Mr. Reid further stated
that the Registrant does not anticipate equipment sales in the fourth quarter
of 2000, however, it estimates that other equipment revenue will be
approximately $800,000 to $900,000. He also stated that the Registrant is
targeting 100% year over year growth in SIMOX wafer sales for 2001, with a
significant portion of the increase expected to occur in the second half of
2001. Mr. Reid also stated that the Registrant anticipates that it may sell
and deliver 1 to 3 implanters at an average selling price of $4-5 million in
the second half of 2001 and that it believes it will start to book orders for
its Ibis 2000 implanter towards the end of 2001.
The information contained in the press release is incorporated herein
by reference and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibit.
99.1 The Registrant's Press Release dated November 28, 2000.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS TECHNOLOGY CORPORATION
(Registrant)
Date: November 28, 2000 /s/ Debra L. Nelson
----------------------------------------
Debra L. Nelson, Chief Financial Officer
3
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit Sequential
Number Description Page Number
------- ----------- -----------
<S> <C> <C>
99.1 The Registrant's Press Release 5
dated November 28, 2000
</TABLE>
